Chemidox Clinical Trials ( Site 0008) — Lancaster, California

Public research footprint of Chemidox Clinical Trials ( Site 0008), compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Atopic Dermatitis · COVID-19 · Treponema Pallidum Infection · Diabetes Mellitus, Type 2

Recently updated registry entries

NCT07216482 — A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037) (Active Not Recruiting)
NCT06316297 — Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With… (Recruiting)
NCT05899816 — A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Chemidox Clinical Trials ( Site 0008)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.